These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15173893)

  • 21. Imaging genetics.
    Gerber AJ; Peterson BS; Muñoz KE; Hyde LW; Hariri AR
    J Am Acad Child Adolesc Psychiatry; 2009 Apr; 48(4):356-361. PubMed ID: 19318879
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobiology of suicidal behaviour.
    Mann JJ
    Nat Rev Neurosci; 2003 Oct; 4(10):819-28. PubMed ID: 14523381
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
    Béïque JC; Lavoie N; de Montigny C; Debonnel G
    Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors in active duty military personnel.
    Bourgeois JA
    Mil Med; 2001 Dec; 166(12):ii. PubMed ID: 11778416
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
    Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selective serotonin reuptake inhibitors (SSRI) in childhood and adolescence].
    Stilke D
    Z Kinder Jugendpsychiatr Psychother; 1997 May; 25(2):106-16. PubMed ID: 9459700
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotonin Dysfunction, Aggressive Behavior, and Mental Illness: Exploring the Link Using a Dimensional Approach.
    Manchia M; Carpiniello B; Valtorta F; Comai S
    ACS Chem Neurosci; 2017 May; 8(5):961-972. PubMed ID: 28378993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized anxiety disorder: rethinking diagnosis and rating.
    Stein DJ
    CNS Spectr; 2005 Dec; 10(12):930-4. PubMed ID: 16344829
    [No Abstract]   [Full Text] [Related]  

  • 31. Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
    Sokolski KN; Gripeos D
    Ann Pharmacother; 2008 Sep; 42(9):1348-9. PubMed ID: 18682539
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
    Blier P; Szabo ST
    J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serotonin-norepinephrine reuptake inhibitors in psychiatry and neurology].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):141-146. PubMed ID: 34481450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of adaptive regulation in the pathophysiology of psychiatric disease.
    Mandell AJ
    J Psychiatr Res; 1974; 11():173-9. PubMed ID: 4142643
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.
    Marek GJ; Carpenter LL; McDougle CJ; Price LH
    Neuropsychopharmacology; 2003 Feb; 28(2):402-12. PubMed ID: 12589395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
    Eriksson E
    Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake.
    Pinna G; Costa E; Guidotti A
    Curr Opin Pharmacol; 2009 Feb; 9(1):24-30. PubMed ID: 19157982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biogenic amines and their impact in psychiatry.
    Axelrod J
    Semin Psychiatry; 1972 Aug; 4(3):199-210. PubMed ID: 4680221
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormone-specific psychiatric disorders: do they exist?
    Altemus M
    Arch Womens Ment Health; 2010 Feb; 13(1):25-6. PubMed ID: 20127449
    [No Abstract]   [Full Text] [Related]  

  • 40. Discrepancies between the in vitro and in vivo 5-HT and norepinephrine re-uptake blocking properties of venlafaxine.
    Béïque JC; Debonnel G; de Montigny C; Blier P
    Ann N Y Acad Sci; 1998 Dec; 861():290-1. PubMed ID: 9928296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.